Spyke

Syndicated from the fediverse. Read and engage on the original instance.

View original on piefed.social
psychology·PsychologybyRimu

Luvesilocin: This new psychedelic drug could change how we treat postpartum depression

In the Phase 2 study, 77% of postpartum women who received a psychedelic dose, 30mg of luvesilocin, had significant improvement in their postpartum depression. Overall, 71% had no symptoms of postpartum depression seven days after the psychedelic session.

Luvesilocin: This new psychedelic drug could change how we treat postpartum depressionhttps://www.psypost.org/luvesilocin-fda-trials-reveal-a-new-psychedelic-could-quickly-clear-postpartum-depression-symptoms/Open linkView original on piefed.social
18
Comments6

6 replies

Rimureply
piefed.social

Take some MDMA and you'll know how you feel!

According to peer-reviewed research published by Bessel van der Kolk in 2024, MDMA can lead to improvements in individuals being able to identify, describe and feel their feelings. Other improvements resulting from MDMA assisted therapy include more self-compassion and a broader desire and capacity for connection with others.

6
IAmYouButYouDontKnowYetreply
reddthat.com

Haven't tried mdma. I love mushrooms though.

I just feel like they are reinventing it to remarket and sell, and that is an insult to the process of using them as a true gift?

Other Mushroom analogs are available... I wonder if this is similar to them.

5
SailorFuzzreply
lemmy.world

It's literally a plot in "Common Side Effects".

There exists a mushroom that can magically and fully cure people... but instead of that, can big pharma synthesize a controlled approximate that doesn't cure people but does exceeds competitors. Thereby ensuring repeat customers and profiting by withholding the real cure.

3

You reached the end

Luvesilocin: This new psychedelic drug could change how we treat postpartum depression | Spyke